Europlasma Sa Stock Three Year Return
ALEUP Stock | EUR 0.1 0.03 20.83% |
Europlasma SA fundamentals help investors to digest information that contributes to Europlasma's financial success or failures. It also enables traders to predict the movement of Europlasma Stock. The fundamental analysis module provides a way to measure Europlasma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Europlasma stock.
Europlasma |
Europlasma SA Company Three Year Return Analysis
Europlasma's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
Competition |
Based on the latest financial disclosure, Europlasma SA has a Three Year Return of 0.0%. This indicator is about the same for the Commercial Services & Supplies average (which is currently at 0.0) sector and about the same as Industrials (which currently averages 0.0) industry. This indicator is about the same for all France stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
All Next | Launch Module |
Europlasma Fundamentals
Return On Equity | -1.1 | |||
Return On Asset | -0.19 | |||
Profit Margin | (0.27) % | |||
Operating Margin | (0.84) % | |||
Current Valuation | 6.76 M | |||
Shares Outstanding | 5.59 M | |||
Price To Earning | (0.93) X | |||
Price To Book | 0.26 X | |||
Price To Sales | 0.55 X | |||
Revenue | 9.8 M | |||
Gross Profit | 5.65 M | |||
EBITDA | (4.02 M) | |||
Net Income | (12.67 M) | |||
Cash And Equivalents | 3.92 M | |||
Cash Per Share | 0.02 X | |||
Total Debt | 2.92 M | |||
Debt To Equity | 769.60 % | |||
Current Ratio | 0.41 X | |||
Book Value Per Share | 324.39 X | |||
Cash Flow From Operations | (18.21 M) | |||
Earnings Per Share | (4,055) X | |||
Target Price | 0.3 | |||
Number Of Employees | 126 | |||
Beta | 0.72 | |||
Market Capitalization | 9.33 M | |||
Total Asset | 40.44 M | |||
Retained Earnings | (57 M) | |||
Working Capital | (9 M) | |||
Current Asset | 20 M | |||
Current Liabilities | 29 M | |||
Z Score | 0.4 | |||
Net Asset | 40.44 M |
About Europlasma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Europlasma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Europlasma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Europlasma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.